Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study (Q40505651)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study
scientific article

    Statements

    Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study (English)
    Miguel A Sanz
    Arancha Bermúdez
    Montserrat Rovira
    Juan Besalduch
    Maria-Jesus Pascual
    Gonzalo Nocea
    César Sanz-Rodríguez
    COSTINE Study Group
    1 May 2005
    645-655

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit